RESEARCH ATLASRESEARCH > HYPE
PUBLIC RESEARCH EDITION
Skin / pigmentation

Melanotan I

Mechanism not verified by source image · Peptide

Evidence at a glance

Each record keeps its own evidence class. Counts are records in this public edition, not a quality score.

Open in the interactive library →Compare with other compounds →

Records (1)

H

Human clinical / research

Human clinical / research

Afamelanotide SCENESSE implant label

Administration reported for this specific study or labeled indication.

Context: Adults with erythropoietic protoporphyria and a history of phototoxic reactions

Approved product label: Amount: 16 mg; Route: Subcutaneous implant; Frequency: Every two months; Species: Human; Population: Adults with erythropoietic protoporphyria and a history of phototoxic reactions

Limitations: The pharmaceutical implant increases pain-free light exposure under its labeled indication.

Route: Subcutaneous implant

Open this exact record in the library →Suggest a correction
CONTINUE THE RESEARCH

Follow the pathway.

No other compound in this public edition uses this pathway label.

Browse this pathway in the library →

Educational research summary. Study amounts are research context, not a dose recommendation. Not medical advice.